Esomeprazole Product Presentation for MPO's. The primary uses of esomeprazole are gastroesophageal reflux disease, treatment and maintenance of erosive esophagitis, treatment of duodenal ulcers caused by H. pylori, prevention of gastric ulcers in those on chronic NSAID therapy, and treatment of gastrointestinal ulcers associated with Crohn's disease.

1. ESMED
Esomeprazole
The most advanced proton pump inhibitor for acid regulation…

2. Product Profile
 Brand Name: Esmed
 Dosage Form: Tablet,Capsule
 Generic: Esomeprazole
 Therapeutic Class: Anti-Ulcerant
 Strength: 20mg,40mg
 Pack Size:
 Price:

3. MedRx Offers…
Product Profile

4. Market Analysis
 Total Pharma Market Value:
 Growing at rate:
 Value of PPI Market:
 Market Share of Esomeprazole:
 Growing at rate:of Esomeprazole:

5. Indication
Gastro Esophageal Reflux Disease
(GERD):

6. Indication
Heartburn:

7. Side Effect:
 Headache
 Flatulence
 Nausea
 Dry Mouth/Diarrhoea
Precautions:
 Safety & Efficacy in pediatric patients and in
pregnant women and nursing mother have not
been established.
Side Effects & Precaution

8. Mechanism of Action-PPI Inhibitors

9. Mechanism of Action-PPI Inhibitors

10. Competitive Analysis (PH Maintaining Time Period)
0
5
10
15
20
Esomeprazole Lansoprazole Rabeprazole Pantoprazole Omeprazole
Duration PH>4 Time Period (Hrs)

11. Dosage & Administration
Indication Dose(mg) Duration
Healing of erosive
esophagitis
20-40 4-8 weeks
Symptomatic relief of GERD 20 4 weeks
To prevent GERD 20
Once Daily for up to 6
Months
For eradication of H.pylori
Infection
40
Once Daily for up to 10
Months

12. SWOT Analysis
Strengths Weaknesses Opportunities Threats
*Management of
multiple
Indications
*Fixed Dose
Combination
*Company with
well trained
workforce
*Late Entrance
*Cant be given in
Pregnancy &
Lactating Females
*Issue in
paediatric Patients
(Use Only in above
12 years of age)
*Growing
Therapeutic
Segment
*Increase Patients
*High Market Value
*High
competitors
*New
Combinations for
indication

13. Product Positioning
Target Doctors Positioning
Gastroenterologist, Medicine
specialist ,Cardiologist
GERD (Gastro-esophageal Reflux Disease),
PUD (Peptic Ulcer Disease) & NSAID-Induced
Ulcer, Erosive Esophagitis, & Zollinger-Ellison
Syndrome
Gynaecologist, Orthopedician,
Dentist, Potential GP, RMP/PC
PUD (Peptic Ulcer Disease) & NSAID-Induced
Ulcer,Erosive esophagitis,Heartburn

14. Key Selling Points
 Higher systemic bioavailability (90%)
 Ensures improved efficacy compared to
Omeprazole
 Excellent healing rate (87%) in Erosive
Esophagitis
 High Success rate in GERD (Gastro-
esophageal Reflux Disease) which is 93.7%
 Immediate Relief from heartburn(Within 60
Sec)